Showing results (41-50 of 109) with videos related to
Sort By:
Pageof 11
Journal of the Peripheral Nervous System : JPNS|August 17, 2024
Long-term and low-dose rituximab treatment for chronic inflammatory demyelinating polyneuropathyYongsheng Zheng, Chong Sun, Yanyin Zhao, et al.Neuromuscular Disorders : NMD|August 10, 2015
Muscle pathology and whole-body MRI in a polyglucosan myopathy associated with a novel glycogenin-1 mutationSushan Luo, Wenhua Zhu, Dongyue Yue, et al.Neuromuscular Disorders : NMD|December 16, 2014
New disease allele and de novo mutation indicate mutational vulnerability of titin exon 343 in hereditary myopathy with early respiratory failureDongyue Yue, Mingshi Gao, Wenhua Zhu, et al.Scientific Reports|June 28, 2018
Hypokalaemic periodic paralysis and myotonia in a patient with homozygous mutation p.R1451L in Na<sub>V</sub>1.4Sushan Luo, Marisol Sampedro Castañeda, Emma Matthews, et al.European Neurology|June 12, 2020
Adult Ocular Myasthenia Gravis Conversion: A Single-Center Retrospective Analysis in ChinaXuelin Feng, Xiao Huan, Chong Yan, et al.Frontiers in Neurology|February 15, 2024
Insights into refractory chronic inflammatory demyelinating polyneuropathy: a comprehensive real-world studyYongsheng Zheng, Jianian Hu, Chong Sun, et al.Journal of Neurology|May 17, 2023
Effectiveness and safety of rituximab in autoimmune nodopathy: a single-center cohort studyBingyou Liu, Jianian Hu, Chong Sun, et al.Annals of Clinical and Translational Neurology|December 18, 2025
In-Depth Profiling Highlights the Effect of Efgartigimod on Peripheral Innate and Adaptive Immune Cells in Myasthenia GravisLei Jin, Liu Dong, Ying Wang, et al.The American Journal of Cardiology|July 28, 2016
Identification of LAMP2 Mutations in Early-Onset Danon Disease With Hypertrophic Cardiomyopathy by Targeted Next-Generation SequencingLijun Fu, Sushan Luo, Shuang Cai, et al.Frontiers in Neurology|February 18, 2022
Update on the Pathogenesis, Clinical Diagnosis, and Treatment of Hirayama DiseaseHongwei Wang, Ye Tian, Jianwei Wu, et al.Pageof 11